4//SEC Filing
Pearson J. Michael 4
Accession 0000885590-11-000023
CIK 0000885590other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 9:40 PM ET
Size
5.3 KB
Accession
0000885590-11-000023
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Shares, no par value
2011-04-21$54.05/sh−235,793$12,744,612→ 5,414,861 total
Footnotes (2)
- [F1]Common shares withheld from the issuance of common shares to the Reporting Person to satisfy the tax withholding obligations due upon vesting of Long-Term Performance Units.
- [F2]This number represents common shares received upon vesting of Long-Term Performance Units, as well as Restricted Share Units and Long-Term Performance Units that were previously reported in Table I of a Form 4 filed on September 30, 2010.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001426004
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 9:40 PM ET
- Size
- 5.3 KB